![SureSelect Cancer Tumor-Specific Assays SureSelect Cancer Tumor-Specific Assays](/cs/publishingimages/5280-0036-Product-Images-320x320.jpg)
SureSelect Cancer Tumor-Specific Assays
Powered by SureSelect XT HS2 library preparation and target enrichment reagents, the assays feature fast hybridization, low sample input, enzymatic fragmentation, and a one-day workflow to generate NGS sequencing-ready libraries. Automation options reduce hands-on time to maximize lab efficiency.